Author

Aydoğan Aydoğdu

Observed names: A Aydogdu, A. Aydogdu, A. Aydoğdu, Aydogan AYDOGDU, Aydogan Aydogdu, Aydogan Aydoğdu, Aydogdu, Aydogan, Aydoğan AYDOĞDU
ORCID: 0000-0002-7983-1119
Observed ORCID: 0000-0002-7983-1119
OpenAlex ID: A5083333605
2012 · Yusuf C. Doganer, Umit Aydogan, et al. · Coronary Artery Disease · 33
2010 · Alper Sonmez, Cem Haymana, et al. · Endocrine · 33
2012 · Ilker Tasci, Hasan Kutsi Kabul, et al. · The Anatolian Journal of Cardiology · 30
2008 · Yasar Kucukardali, Sebnem Aydogdu, et al. · Cardiovascular revascularization medicine · 30
2012 · Aydogan Aydogdu, Ilker Tasci, et al. · Gynecological Endocrinology · 28
2016 · Aydogan Aydogdu, Ronald S. Swerdloff · Expert Opinion on Emerging Drugs · 27
2013 · Ilker Tasci, Mehmet Naharci, et al. · Endocrine Metabolic & Immune Disorders - Drug Targets · 27
2010 · Alper Sonmez, Zeynep Yilmaz, et al. · Diabetes Technology & Therapeutics · 25
2015 · Polat Nerkiz, Yusuf Cetin Doganer, et al. · Medical Principles and Practice · 22
2017 · Cem Haymana, Alper Sonmez, et al. · Archives of Endocrinology and Metabolism · 15
2018 · Cem Haymana, Aydogan Aydogdu, et al. · Endocrine Metabolic & Immune Disorders - Drug Targets · 13
2013 · E. Bolu, A. Sonmez, et al. · Hormone and Metabolic Research · 11
2017 · C. Haymana, A. Aydoğdu, et al. · Toxicology Mechanisms and Methods · 10
2016 · Ilker Tasci, Umut Safer, et al. · Endocrine Metabolic & Immune Disorders - Drug Targets · 8
Works count: 76
Citation count: 698
H-index: 15
I10-index: 24
Year
Topic
Type